A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies

被引:295
作者
Bosco, Jaclyn L. F. [1 ,2 ]
Silliman, Rebecca A. [1 ,2 ]
Thwin, Soe Soe [1 ]
Geiger, Ann M. [3 ]
Buist, Diana S. M. [4 ]
Prout, Marianne N. [2 ]
Yood, Marianne Ulcickas [5 ]
Haque, Reina [6 ]
Wei, Feifei [7 ]
Lash, Timothy L. [1 ,2 ]
机构
[1] Boston Univ, Med Ctr, Dept Med, Geriatr Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA
[4] Grp Hlth Ctr Hlth Studies, Seattle, WA USA
[5] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[6] Kaiser Permanente So Calif, Pasadena, CA USA
[7] HealthPartners Res Fdn, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Confounding by indication; Propensity score; Instrumental variable; Nonrandomized studies; Breast cancer; Chemotherapy; INSTRUMENTAL VARIABLES; PROPENSITY SCORE; BREAST-CANCER; OLDER WOMEN; ADJUVANT CHEMOTHERAPY; OUTCOMES; REGRESSION; MORTALITY; SURVIVAL; THERAPY;
D O I
10.1016/j.jclinepi.2009.03.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To evaluate the effectiveness of methods that control for confounding by indication, we compared breast cancer recurrence rates among women receiving adjuvant chemotherapy with those who did not. Study Design and Setting: In a medical record review-based study of breast cancer treatment in older women (n = 1798) diagnosed between 1990 and 1994, our crude analysis suggested that adjuvant chemotherapy was positively associated with recurrence (hazard ratio [HR] = 2.6; 95% confidence interval [CI] = 1.9, 3.5). We expected a protective effect, so postulated that the crude association was confounded by indications for chemotherapy. We attempted to adjust for this confounding by restriction, multivariable regression, propensity scores (PSs), and instrumental variable (IV) methods. Results: After restricting to women at high risk for recurrence (it = 946), chemotherapy was not associated with recurrence (HR = 1.1; 95% CI = 0.7, 1.6) using multivariable regression. PS adjustment yielded similar results (HR = 1.3; 95% CI = 0.8, 2.0). The IV-like method yielded a protective estimate (HR = 0.9; 95% CI = 0.2, 4.3); however, imbalances of measured factors across levels of the IV suggested residual confounding, Conclusion: Conventional methods do not control for unmeasured factors, which often remain important when addressing confounding by indication. PS and IV analysis methods can be useful under specific situations, but neither method adequately controlled confounding by indication in this study. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 74
页数:11
相关论文
共 39 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   In defense of pharmacoepidemiology - Embracing the yin and yan of drug research [J].
Avorn, Jerry .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2219-2221
[3]   PROBLEMS WITH INSTRUMENTAL VARIABLES ESTIMATION WHEN THE CORRELATION BETWEEN THE INSTRUMENTS AND THE ENDOGENOUS EXPLANATORY VARIABLE IS WEAK [J].
BOUND, J ;
JAEGER, DA ;
BAKER, RM .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1995, 90 (430) :443-450
[4]  
Brookhart M Alan, 2007, Int J Biostat, V3, P14
[5]   Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable [J].
Brookhart, MA ;
Wang, PS ;
Solomon, DH ;
Schneeweiss, S .
EPIDEMIOLOGY, 2006, 17 (03) :268-275
[6]   Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders [J].
Cepeda, MS ;
Boston, R ;
Farrar, JT ;
Strom, BL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (03) :280-287
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women [J].
Du, XLL ;
Jones, DV ;
Zhang, D .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (09) :1137-1144
[9]   Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort [J].
Elkin, Elena B. ;
Hurria, Arti ;
Mitra, Nandita ;
Schrag, Deborah ;
Panageas, Katherine S. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2757-2764
[10]   Breast cancer treatment of older women in integrated health care settings [J].
Enger, Shelley M. ;
Thwin, Soe Soe ;
Buist, Diana S. M. ;
Field, Terry ;
Frost, Floyd ;
Geiger, Ann M. ;
Lash, Timothy L. ;
Prout, Marianne ;
Yood, Marianne Ulcickas ;
Wei, Feifei ;
Silliman, Rebecca A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4377-4383